Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the KneeRecruiting
NCT03588975Phase 3Updated Sep 10, 2026
Sponsor: Vericel Corporation
Chondral Defect · Osteochondritis Dissecans (OCD) · Articular Cartilage Defect · Articular Cartilage Disorder of Knee
United States
Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLCRecruiting
NCT07554846Phase 3Updated Sep 10, 2026
Sponsor: Fudan University
Resectable Stage II-IIIa NSCLC
China
Vorasidenib Maintenance for IDH Mutant AstrocytomaRecruiting
NCT06809322Phase 3Updated Sep 10, 2026
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
IDH-mutant Grade 2 or 3 Astrocytoma
Australia, Austria, Belgium, Canada, Czechia +7 more
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal SarcomaRecruiting
NCT04031677Phase 3Updated Sep 10, 2026
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Retroperitoneal Sarcoma · Liposarcoma · Leiomyosarcoma
United States, Australia, Canada, Cyprus, Czechia +10 more
APPLE: Aspirin to Prevent Pregnancy Loss and PreeclampsiaRecruiting
NCT06408181Phase 3Updated Sep 10, 2026
Sponsor: University of Pennsylvania
Pre-Eclampsia · Pregnancy Loss
United States
A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)Recruiting
NCT07013487Phase 3Updated Sep 10, 2026
Sponsor: Merck Sharp & Dohme LLC
Healthy
Indonesia, Malaysia, Philippines, Puerto Rico, Singapore +2 more
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and OsteoarthritisRecruiting
NCT07339111Phase 3Updated Sep 10, 2026
Sponsor: Medipost, Inc.
Knee Cartilage Defects
United States
STOP-HAE: A Phase 3 Study of ADX-324 in HAERecruiting
NCT06960213Phase 3Updated Sep 10, 2026
Sponsor: ADARx Pharmaceuticals, Inc.
Hereditary Angioedema · HAE · Hereditary Angioedema - Type 1 · Hereditary Angioedema - Type 2
United States, Argentina, Australia, Austria, Belgium +19 more
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusRecruiting
NCT07776509Phase 3Updated Sep 10, 2026
Sponsor: AstraZeneca
Obesity or Overweight · Weight-Related Comorbidity · With/Without Diabetes Mellitus, Type 2
United States, Argentina, Brazil, Canada, China +6 more
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsRecruiting
NCT06008197Phase 3Updated Sep 10, 2026
Sponsor: Colorado Prevention Center
Heart Failure · Acute Heart Failure
United States, Argentina, Australia, Brazil, Bulgaria +21 more
Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum ResectionRecruiting
NCT05941806Phase 3Updated Sep 10, 2026
Sponsor: CHU de Quebec-Universite Laval
Urinary Retention · Colorectal Surgery · Rectal Resection · Post-operative Urinary Retention
Canada
A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With HyperlipidemiaRecruiting
NCT07230730Phase 3Updated Sep 10, 2026
Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd
Hyperlipidemia
China
A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid LeukemiaRecruiting
NCT07255872Phase 2, Phase 3Updated Sep 10, 2026
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Acute Myeloid Leukemia
China
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE TrialRecruiting
NCT06203600Phase 2, Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Esophageal Adenocarcinoma · Advanced Gastric Adenocarcinoma · Advanced Gastroesophageal Junction Adenocarcinoma · Clinical Stage II Esophageal Adenocarcinoma AJCC v8
United States
Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)Recruiting
NCT07389460Phase 3Updated Sep 9, 2026
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Acute Ischemic Stroke
China
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMRecruiting
NCT07667803Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Weight Management
United States, Argentina, Australia, Brazil, Canada +14 more
A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast CancerRecruiting
NCT07679360Phase 3Updated Sep 9, 2026
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Triple Negative Breast Cancer
China
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia AreataRecruiting
NCT07772492Phase 3Updated Sep 9, 2026
Sponsor: AbbVie
Severe Alopecia Areata
United States
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesRecruiting
NCT07282613Phase 3Updated Sep 9, 2026
Sponsor: Novo Nordisk A/S
Diabetes Mellitus, Type 2
United States, Argentina, Brazil, Colombia, India +5 more
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenRecruiting
NCT07621809Phase 3Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Sjögren´s Disease
United States, Australia, Canada, South Korea
A Study of Eptinezumab in Pediatric Participants With Episodic MigraineRecruiting
NCT05897320Phase 3Updated Sep 9, 2026
Sponsor: H. Lundbeck A/S
Episodic Migraine
United States, Argentina, Canada, Italy, Mexico +6 more
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple MyelomaRecruiting
NCT06980480Phase 3Updated Sep 9, 2026
Sponsor: Takeda
Multiple Myeloma · Secondary Immunodeficiency
United States, Australia, Austria, Brazil, Canada +11 more
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgANRecruiting
NCT06994845Phase 3Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Primary Immunoglobulin A Nephropathy (IgAN)
United States, Argentina, Australia, China, Hong Kong +3 more
Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal CancerRecruiting
NCT06008119Phase 3Updated Sep 9, 2026
Sponsor: Shanghai Kechow Pharma, Inc.
Colorectal Cancer Metastatic
China
Rupatifen Fumarate Capsules in Patients With Seasonal Allergic RhinitisRecruiting
NCT07711262Phase 3Updated Sep 9, 2026
Sponsor: Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.
Seasonal Allergic Rhinitis
China

Previous page Next page